|
Dr. Sharma’s research focus is understanding the pathophysiology of microbiota-gut-brain axis in various conditions and developing innovative, non-invasive, and promising magnetic neuromodulation therapies through his insights, outstanding mentorship and collaboration, and his engineering background. His clinical practice and translational focus involve patients with diabetic gastroparesis, Parkinson’s disease, fecal incontinence, and disorders of gut-brain interaction (DGBIs).
His research has been and is currently funded by the NIH/NIDDK, Parkinson’s Foundation, the American College of Gastroenterology, and industry sponsors. He currently serves as the principal investigator of a NIH-funded multi-center, randomized, sham-controlled study investigating thoracic neuromodulation for diabetic gastroparesis (RO1-DK133520). His lab at the Digestive Health Center (DHC) in Augusta, Georgia, is home to a sophisticated NGM physiology testing, where over 150 research and 3000 clinical motility studies are performed for patients each year. He is indebted to his growing clinical and research team of research coordinators, nurses, advanced practice providers, post-docs and faculty and the overall supportive academic environment of MCG.
Dr. Sharma is grateful for the work of and cherishes his involvement with patient advocacy organizations, such as IFFGD. He is a member of the IFFGD Junior Academician coordinating committee, lectured during the IFFGD 2020 Virtual Advocacy Event, is involved with other IFFGD programs, and led his team, MCG Lucky Sharms, to win Top Academic Institution during IFFGD’s 2023 Virtual Digestive Health Wellness & Walk Event.
| 
